|Bid||59.97 x 900|
|Ask||59.98 x 800|
|Day's range||59.03 - 60.05|
|52-week range||57.49 - 89.70|
|Beta (5Y monthly)||0.60|
|PE ratio (TTM)||29.95|
|Forward dividend & yield||1.16 (1.94%)|
|Ex-dividend date||01 Sept 2022|
|1y target est||N/A|
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Shares of Baxter International (NYSE: BAX) were tumbling 8.8% lower as of 11:24 a.m. ET on Thursday after falling as much as 11.8% earlier in the day. The decline came after the healthcare company announced its second-quarter financial results. The company posted Q2 adjusted earnings per share of $0.87, in line with the average estimate of analysts surveyed by Refinitiv.
Baxter's (BAX) second-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.